Manchester Metropolitan University's Research Repository

    Items where Author is "Kahraman, Turhan"

    Up a level
    Export as [feed] Atom [feed] RSS
    Group by: Item Type | No Grouping
    Jump to: Article
    Number of items: 4.


    Abasıyanık, Zuhal ORCID logoORCID: https://orcid.org/0000-0003-3086-8102, Kahraman, Turhan ORCID logoORCID: https://orcid.org/0000-0002-8776-0664, Baba, Cavid ORCID logoORCID: https://orcid.org/0000-0001-5455-7080, Sağıcı, Özge, Ertekin, Özge ORCID logoORCID: https://orcid.org/0000-0001-9935-0673 and Özakbaş, Serkan ORCID logoORCID: https://orcid.org/0000-0003-2140-4103 (2024) Discriminative ability of the original and short form of the Activities-specific Balance Confidence scale and its individual items for falls in people with multiple sclerosis. Acta Neurologica Belgica, 124 (3). pp. 957-964. ISSN 0300-9009

    Gökşen, Ayşenur ORCID logoORCID: https://orcid.org/0000-0003-2273-5908, Çaylak, Remzi ORCID logoORCID: https://orcid.org/0000-0002-2926-4590, Kübra Çekok, Fatma ORCID logoORCID: https://orcid.org/0000-0001-8865-660X and Kahraman, Turhan ORCID logoORCID: https://orcid.org/0000-0002-8776-0664 (2024) Translation, cross-cultural adaptation, reliability, and convergent and known-group validity of the Turkish full version of the Hip Disability and Osteoarthritis Outcome Score in patients with hip osteoarthritis. Archives of Rheumatology, 39 (2). pp. 180-193. ISSN 2148-5046

    Kahraman, Turhan, Temiz, Hasretgul, Abasiyanik, Zuhal, Baba, Cavid and Ozakbas, Serkan (2023) Dual‐task difficulties as a risk factor for unemployment in people with multiple sclerosis. Brain and Behavior, 13 (12). ISSN 2162-3279

    Selcuk Muhtaroglu, Ferda, Belgen Kaygisiz, Beliz, Usar Incirli, Sila and Kahraman, Turhan (2023) Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: a triple-blinded, randomized, placebo-controlled pilot trial. Journal of Clinical Neuroscience, 117. pp. 136-142. ISSN 0967-5868

    This list was generated on Fri Jul 19 04:25:11 2024 BST.